Control Group
OtherThis is the control group with 14 h treatment over 10 workdays.
NCT Number: NCT02804412
Constraint-induced aphasia therapy (CIAT) has proven effective in stroke patients. It has remained unclear, however, whether intensity of therapy or constraint is the relevant factor. This study will give an answer to this question to improve speech and language therapy.
Looking for future studies?
Notify Me39 year–89 year
All sexes
Interventional
Not applicable
Although there is clear evidence that aphasia therapy is effective, questions remain as to the intensity of administered therapy, the preferred therapeutic approach and its initiation with regard to stroke onset. CIAT is a a high intense group therapy administered over 2 weeks. Additionally, patients have to communicate solely in spoken words or sentences (constraint). This study compares CIAT with an approach of the same intensity without constraints and a less intense house-typical therapeutic approach.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is the control group with 14 h treatment over 10 workdays.
Examine the efficacy of CIAT (30 h over 10 workdays) versus Control-group and communication treatment group.
Examine the efficacy of CTG (30h over 10 wokrdays) versus CIAT-group and control group
Time frame: pretreatment and within 24 h post intervention
Time frame: pretreatment and within 24 h post intervention
The CAL is a two-part questionnaire rating the amount and the quality of daily communication on a six-point scale
University of Leipzig
Other
Constraint Induced Aphasia Therapy in Stroke Patients in Acute Stage.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04963803
Aphasia, Behavior
Syracuse, New York, United States
View Trial DetailsNCT03272906
Aphasia, Behavior
Baton Rouge, Louisiana, United States
View Trial DetailsNCT03699930
Aphasia, Behavior
Pomona, California, United States
View Trial DetailsNCT04142866
Aphasia, Behavior
New York, United States
View Trial Details